Dr. Neelima Katragunta, MD

Dr. Katragunta practices at Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health.

Dr. Katragunta's NPI, 1912188236, was assigned on November 15, 2007. Dr. Katragunta holds Tennessee license 62333.

Dr. Katragunta's primary practice is Erlanger Baroness Hospital, at 975 E 3rd St, Chattanooga, TN 37403 in Hamilton County. The practice phone is (423) 778-7000.

Dr. Katragunta's primary practice is Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health. Dr. Katragunta is also affiliated with CommonSpirit - Memorial Hospital - Chattanooga. The medical group on file is Erlanger. Dmand AI also links Dr. Katragunta to 1 more hospital, 5 medical groups, 2 group practices and clinics and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katragunta practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Katragunta's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Katragunta's licenses on file in 2 states: Tennessee and Iowa.

CMS data shows 792 Medicare services from Dr. Katragunta across 19 procedure codes in 2024, for 520 Medicare patients. Medicare paid $64,098 for them.

CMS counts 520 Medicare patients who saw Dr. Katragunta in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katragunta's median patient age at 66, with 51% women.

In 2024, Dr. Katragunta wrote 479 Medicare Part D claims for 133 patients. 78% of them were for generic drugs. CMS names the drug for 431 of them, across 7 drugs with 11 or more claims each, at $71,143 in total drug cost. In 2023, CMS named 380 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Katragunta for performance year 2024, reported through an alternative payment model (APM). Dr. Katragunta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of leg revascularization (restoring blood flow) by Dr. Katragunta, more than 64% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Katragunta, published from 2017 to 2018. Dr. Katragunta's most frequent co-authors are William J. Sharp, MD, Mark W. Fugate, MD and Elizabeth Hatcher Hartmann, MD.

CMS Open Payments shows 199 general payments to Dr. Katragunta from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. ShockWave Medical, Inc paid the most, $13,279.